Vimarsana
Biggest News Aggregation in the World

Page 2 - Program On Regulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Program On Regulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Program On Regulation Today - Breaking & Trending Today

Lifetime Cost of DEB Gene Therapy Could Be $15-$22 Million - Vimarsana News

Lifetime Cost of DEB Gene Therapy Could Be $15-$22 Million

The most expensive gene therapy on the US market may give payers pause, said study authors.

Feds assert rights to march-in on drug patents over price : Shots - Vimarsana News

Feds assert rights to march-in on drug patents over price : Shots

To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.

Source: npr.org
White House proposes to 'march in' on patents for costly drugs - Vimarsana News

White House proposes to 'march in' on patents for costly drugs

To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.

White House proposes to 'march in' on patents for costly drugs - Vimarsana News

White House proposes to 'march in' on patents for costly drugs

To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.

White House proposes to 'march in' on patents for costly drugs - Vimarsana News

White House proposes to 'march in' on patents for costly drugs

To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.